Global Codeine 麻豆原创 Growth 2025-2031

Publication ID:

LPI01253069

Publication Date:

January 29, 2025

Pages:

114

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Codeine market size is predicted to grow from US$ 239 million in 2025 to US$ 168 million in 2031; it is expected to grow at a CAGR of -5.7% from 2025 to 2031.
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
麻豆原创 competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.
The 鈥淐odeine Industry Forecast鈥� looks at past sales and reviews total world Codeine sales in 2024, providing a comprehensive analysis by region and market sector of projected Codeine sales for 2025 through 2031. With Codeine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Codeine industry.
This Insight Report provides a comprehensive analysis of the global Codeine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Codeine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Codeine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Codeine and breaks down the forecast by Ingredient, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Codeine.
This report presents a comprehensive overview, market shares, and growth opportunities of Codeine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Ingredient:
Single-ingredient Codeine
Multi-ingredient Medications
Segmentation by Application:
Narcotic Analgesic
Antitussive
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Key Questions Addressed in this Report
What is the 10-year outlook for the global Codeine market?
What factors are driving Codeine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Codeine market opportunities vary by end market size?
How does Codeine break out by Ingredient, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Codeine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Codeine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Codeine by Country/Region, 2020, 2024 & 2031
2.2 Codeine Segment by Ingredient
2.2.1 Single-ingredient Codeine
2.2.2 Multi-ingredient Medications
2.3 Codeine Sales by Ingredient
2.3.1 Global Codeine Sales 麻豆原创 Share by Ingredient (2020-2025)
2.3.2 Global Codeine Revenue and 麻豆原创 Share by Ingredient (2020-2025)
2.3.3 Global Codeine Sale Price by Ingredient (2020-2025)
2.4 Codeine Segment by Application
2.4.1 Narcotic Analgesic
2.4.2 Antitussive
2.4.3 Others
2.5 Codeine Sales by Application
2.5.1 Global Codeine Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Codeine Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Codeine Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Codeine Breakdown Data by Company
3.1.1 Global Codeine Annual Sales by Company (2020-2025)
3.1.2 Global Codeine Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Codeine Annual Revenue by Company (2020-2025)
3.2.1 Global Codeine Revenue by Company (2020-2025)
3.2.2 Global Codeine Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Codeine Sale Price by Company
3.4 Key Manufacturers Codeine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Codeine Product Location Distribution
3.4.2 Players Codeine Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Codeine by Geographic Region
4.1 World Historic Codeine 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Codeine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Codeine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Codeine 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Codeine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Codeine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Codeine Sales Growth
4.4 APAC Codeine Sales Growth
4.5 Europe Codeine Sales Growth
4.6 Middle East & Africa Codeine Sales Growth
5 Americas
5.1 Americas Codeine Sales by Country
5.1.1 Americas Codeine Sales by Country (2020-2025)
5.1.2 Americas Codeine Revenue by Country (2020-2025)
5.2 Americas Codeine Sales by Ingredient (2020-2025)
5.3 Americas Codeine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Codeine Sales by Region
6.1.1 APAC Codeine Sales by Region (2020-2025)
6.1.2 APAC Codeine Revenue by Region (2020-2025)
6.2 APAC Codeine Sales by Ingredient (2020-2025)
6.3 APAC Codeine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Codeine by Country
7.1.1 Europe Codeine Sales by Country (2020-2025)
7.1.2 Europe Codeine Revenue by Country (2020-2025)
7.2 Europe Codeine Sales by Ingredient (2020-2025)
7.3 Europe Codeine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Codeine by Country
8.1.1 Middle East & Africa Codeine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Codeine Revenue by Country (2020-2025)
8.2 Middle East & Africa Codeine Sales by Ingredient (2020-2025)
8.3 Middle East & Africa Codeine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Codeine
10.3 Manufacturing Process Analysis of Codeine
10.4 Industry Chain Structure of Codeine
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Codeine Distributors
11.3 Codeine Customer
12 World Forecast Review for Codeine by Geographic Region
12.1 Global Codeine 麻豆原创 Size Forecast by Region
12.1.1 Global Codeine Forecast by Region (2026-2031)
12.1.2 Global Codeine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Codeine Forecast by Ingredient (2026-2031)
12.7 Global Codeine Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Taiji
13.1.1 Taiji Company Information
13.1.2 Taiji Codeine Product Portfolios and Specifications
13.1.3 Taiji Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Taiji Main Business Overview
13.1.5 Taiji Latest Developments
13.2 Mallinckrodt
13.2.1 Mallinckrodt Company Information
13.2.2 Mallinckrodt Codeine Product Portfolios and Specifications
13.2.3 Mallinckrodt Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mallinckrodt Main Business Overview
13.2.5 Mallinckrodt Latest Developments
13.3 TEVA
13.3.1 TEVA Company Information
13.3.2 TEVA Codeine Product Portfolios and Specifications
13.3.3 TEVA Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 TEVA Main Business Overview
13.3.5 TEVA Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Codeine Product Portfolios and Specifications
13.4.3 Johnson & Johnson Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Medreich
13.5.1 Medreich Company Information
13.5.2 Medreich Codeine Product Portfolios and Specifications
13.5.3 Medreich Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Medreich Main Business Overview
13.5.5 Medreich Latest Developments
13.6 Sanofi Aventis
13.6.1 Sanofi Aventis Company Information
13.6.2 Sanofi Aventis Codeine Product Portfolios and Specifications
13.6.3 Sanofi Aventis Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sanofi Aventis Main Business Overview
13.6.5 Sanofi Aventis Latest Developments
13.7 Cipla
13.7.1 Cipla Company Information
13.7.2 Cipla Codeine Product Portfolios and Specifications
13.7.3 Cipla Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Cipla Main Business Overview
13.7.5 Cipla Latest Developments
13.8 Hikma
13.8.1 Hikma Company Information
13.8.2 Hikma Codeine Product Portfolios and Specifications
13.8.3 Hikma Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Hikma Main Business Overview
13.8.5 Hikma Latest Developments
13.9 Pharmaceutical Associates
13.9.1 Pharmaceutical Associates Company Information
13.9.2 Pharmaceutical Associates Codeine Product Portfolios and Specifications
13.9.3 Pharmaceutical Associates Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Pharmaceutical Associates Main Business Overview
13.9.5 Pharmaceutical Associates Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Codeine Product Portfolios and Specifications
13.10.3 Novartis Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Apotex
13.11.1 Apotex Company Information
13.11.2 Apotex Codeine Product Portfolios and Specifications
13.11.3 Apotex Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Apotex Main Business Overview
13.11.5 Apotex Latest Developments
13.12 Mylan
13.12.1 Mylan Company Information
13.12.2 Mylan Codeine Product Portfolios and Specifications
13.12.3 Mylan Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Mylan Main Business Overview
13.12.5 Mylan Latest Developments
13.13 Aristo Pharma GmbH
13.13.1 Aristo Pharma GmbH Company Information
13.13.2 Aristo Pharma GmbH Codeine Product Portfolios and Specifications
13.13.3 Aristo Pharma GmbH Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Aristo Pharma GmbH Main Business Overview
13.13.5 Aristo Pharma GmbH Latest Developments
13.14 Lannett Company
13.14.1 Lannett Company Company Information
13.14.2 Lannett Company Codeine Product Portfolios and Specifications
13.14.3 Lannett Company Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Lannett Company Main Business Overview
13.14.5 Lannett Company Latest Developments
13.15 Laboratoire Riva
13.15.1 Laboratoire Riva Company Information
13.15.2 Laboratoire Riva Codeine Product Portfolios and Specifications
13.15.3 Laboratoire Riva Codeine Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Laboratoire Riva Main Business Overview
13.15.5 Laboratoire Riva Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.